Marker Therapeutics, Inc.
MRKR · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Knobil Katharine: Form 4
Insider disclosure · Filed · Report period 17 Nov 2025
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001094038 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- MRKR on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2450 Holcombe Blvd, Tmc Partners Office 1.311, Houston, TX, 77021
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- TAPIMMUNE INC. (to 17 Oct 2018), TAPIMMUNE INC (to 29 Jun 2017), GENEMAX CORP (to 28 Jun 2007), EDUVERSE COM (to 17 Jun 2002)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields